Bruton's tyrosine kinase (BTK), a pivotal enzyme within the cellular milieu of B cell development and function, stands as a linchpin in the intricate orchestration of B cell receptor (BCR) signaling. Integral to the finely tuned machinery of the immune system, BTK plays a pivotal role in transducing signals that govern B cell activation, development, and the subsequent production of antibodies-a fundamental defense mechanism against diverse pathogens. The significance of BTK in immune function is underscored by the manifestation of X-linked agammaglobulinemia (XLA) resulting from mutations in the BTK gene, a primary immunodeficiency disorder characterized by the absence of mature B cells and a marked deficiency in immunoglobulins.
Within the realm of molecular modulation, a distinctive class of compounds has emerged-Btk Activators. These chemical entities are specifically designed to interface with and potentiate the catalytic activity of Bruton's tyrosine kinase. Situated predominantly within B cells, the epicenters of humoral immunity, BTK activation constitutes a pivotal juncture in the complex web of signaling events initiated by the BCR. The mechanistic intricacies of BTK activation involve the augmentation of its kinase activity, thereby fostering an intensified BCR signaling cascade. This molecular cascade, orchestrated by Btk activators, assumes a paramount role in shaping immune responses by intricately regulating the processes of B cell activation and subsequent antibody production in response to diverse pathogens. The investigation into Btk activators assumes paramount importance in the scientific landscape, contributing substantially to the unraveling of the complexities inherent in B cell biology. The nuanced exploration of these activators opens vistas for research applications, laying the foundation for a deeper comprehension of immune processes. Delving into the molecular mechanisms underpinning BTK activation not only advances our fundamental understanding of B cell physiology but also paves the way for the development of innovative tools capable of finely modulating immune responses.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lipopolysaccharide, E. coli O55:B5 | 93572-42-0 | sc-221855 sc-221855A sc-221855B sc-221855C | 10 mg 25 mg 100 mg 500 mg | $98.00 $171.00 $425.00 $1560.00 | 12 | |
Stimulates B cells and can potentially modulate BTK expression. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Known to influence B cell function, though its direct effect on BTK expression isn't well-defined. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Can activate protein kinase C and might influence B cell signaling and BTK expression. | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $96.00 $264.00 | 2 | |
Calcium ionophore that can activate various cell signaling pathways, potentially influencing BTK expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Known to influence immune cell differentiation, though its direct effect on BTK expression isn't clearly documented. | ||||||